Personalis Inc
NASDAQ:PSNL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Personalis Inc
NASDAQ:PSNL
|
US |
|
W
|
W-Scope Chungju Plant Co Ltd
KOSDAQ:393890
|
KR |
|
C
|
Commonwealth Bank of Australia
XMUN:CWW
|
AU |
|
EchoIQ Ltd
ASX:EIQ
|
AU |
Intrinsic Value
Is PSNL undervalued or overvalued?
See the intrinsic value estimate for Personalis Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PSNL looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PSNL’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Personalis Does
Personalis is a cancer genomics company that turns tumor and blood samples into detailed DNA and RNA reports. It sells sequencing tests, laboratory analysis, and data interpretation services that help customers understand how a cancer is changing and whether a treatment is working.
- Headquarters
- United States of America US
- Employees
- 260
- IPO date
- Jun 20, 2019
Revenue & Expenses Breakdown
Personalis Inc
Earnings Waterfall
Personalis Inc
The intrinsic value for Personalis Inc (PSNL) under the Base Case is hidden USD.
Compared with the current market price of 15.88 USD, the stock appears hidden.